Memory Phenotypes In Early, De Novo Parkinson's Disease Patients with Mild Cognitive Impairment
Mattia Siciliano1,2,3, Rosa De Micco1, Andrea Gerardo Russo1
1Department of Advanced Medical and Surgical Sciences-MRI Research Center Vanvitelli-FISM, University of Campania "Luigi Vanvitelli", Naples, Italy.
Background:
Memory deficits in mild cognitive impairment related to Parkinson's disease (PD-MCI) are quite heterogeneous, and there is no general agreement on their genesis.
Objectives:
To define memory phenotypes in de novo PD-MCI and their associations with motor and non-motor features and patients' quality of life.
Methods:
From a sample of 183 early de novo patients with PD, cluster analysis was applied to neuropsychological measures of memory function of 82 patients with PD-MCI (44.8%). The remaining patients free of cognitive impairment were considered as a comparison group (n = 101). Cognitive measures and structural magnetic resonance imaging-based neural correlates of memory function were used to substantiate the results.
Results:
A three-cluster model produced the best solution. Cluster A (65.85%) included memory unimpaired patients; Cluster B (23.17%) included patients with mild episodic memory disorder related to a "prefrontal executive-dependent phenotype"; Cluster C (10.97%) included patients with severe episodic memory disorder related to a "hybrid phenotype," where hippocampal-dependent deficits co-occurred with prefrontal executive-dependent memory dysfunctions. Cognitive and brain structural imaging correlates substantiated the findings. The three phenotypes did not differ in terms of motor and non-motor features, but the attention/executive deficits progressively increased from Cluster A, through Cluster B, to Cluster C. This last cluster had worse quality of life compared to others.
Conclusions:
Our results demonstrated the memory heterogeneity of de novo PD-MCI, suggesting existence of three distinct memory-related phenotypes. Identification of such phenotypes can be fruitful in understanding the pathophysiological mechanisms underlying PD-MCI and its subtypes and in guiding appropriate treatments. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Insights
Parkinson's disease with mild cognitive impairment (PD-MCI) presents diverse memory issues. This study identified three distinct memory phenotypes in early PD-MCI patients, aiding in understanding and treatment.
Area of Science:
- Neurology
- Neuroscience
- Cognitive Science
Background:
- Memory deficits in Parkinson's disease with mild cognitive impairment (PD-MCI) are highly variable.
- The underlying causes of these heterogeneous memory impairments remain unclear.
Purpose of the Study:
- To characterize memory phenotypes in de novo PD-MCI patients.
- To investigate associations between memory phenotypes and motor/non-motor features.
- To examine the impact of memory phenotypes on patients' quality of life.
Main Methods:
- Cluster analysis of memory function in 82 de novo PD-MCI patients.
- Comparison with 101 cognitively unimpaired individuals.
- Utilized cognitive measures and structural MRI for neural correlates.
Main Results:
- Identified three memory phenotypes: unimpaired, mild episodic memory disorder (prefrontal executive-dependent), and severe episodic memory disorder (hybrid phenotype).
- Progressive increase in attention/executive deficits across phenotypes.
- The severe memory disorder group reported worse quality of life.
Conclusions:
- De novo PD-MCI exhibits significant memory heterogeneity, manifesting as three distinct phenotypes.
- Phenotype identification is crucial for understanding PD-MCI pathophysiology and subtypes.
- Findings can guide the development of targeted therapeutic strategies for PD-MCI.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Treatment


